| abstract |
Buffered formulations comprising an anionic polysaccharide and lidocaine, bupivacaine or mepivacaine, for use in treating lower urinary tract disorders are provided in the invention. In particular, said buffered formulations demonstrate improvement for treating lower urinary tract symptoms of patients experiencing severe pain and/or urgency of the bladder and associated areas of the lower urinary tract. |